GetTopicDetailResponse(id=1e44389121, topicName=C.difficile, introduction=C.difficile, content=null, image=null, comments=1, allHits=673, url=https://h5.medsci.cn/topic?id=3891, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=32232, tagList=[TagDto(tagId=32232, tagName=C.difficile)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780491, encodeId=5c261e80491ed, content=<a href='/topic/show?id=1e44389121' target=_blank style='color:#2F92EE;'>#C.difficile#</a>, objectTitle=FDA受理默沙東抗毒素產(chǎn)品bezlotoxumab上市申請，預(yù)防艱難梭菌（C.difficile）感染的復(fù)發(fā), objectType=article, longId=62805, objectId=ba81628052f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba81628052f, replyNumber=0, likeNumber=80, createdTime=2016-05-03, rootId=0, userName=ms1490123962508630, userId=ca772500164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba81628052f, moduleTitle=FDA受理默沙東抗毒素產(chǎn)品bezlotoxumab上市申請，預(yù)防艱難梭菌（C.difficile）感染的復(fù)發(fā), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ba81628052f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
